PREPARATION OF MOUSE-HUMAN CHIMERIC ANTIBODY TO AN EMBRYONIC CARBOHYDRATE ANTIGEN, LEWIS-Y

被引:13
作者
KANEKO, T
IBA, Y
ZENITA, K
SHIGETA, K
NAKANO, K
ITOH, W
KUROSAWA, Y
KANNAGI, R
YASUKAWA, K
机构
[1] TOSOH CORP,BIOTECHNOL RES LAB,2743-1 HAYAKAWA,AYASE,KANAGAWA 252,JAPAN
[2] FUJITA HLTH UNIV,INST COMPREHENS MED SCI,TOYOAKE,AICHI 47011,JAPAN
[3] AICHI CANC CTR,RES INST,EXPTL PATHOL LAB,NAGOYA,AICHI 464,JAPAN
关键词
D O I
10.1093/oxfordjournals.jbchem.a123993
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stage-specific embryonic antigen-1 (SSEA-1) is a well-known carbohydrate antigen that is specifically expressed on the surface of cancer cells as well as embryonic cells. In this study, starting with a previously established hybridoma producing a monoclonal antibody (named H18A) to Lewis Y antigen, which is closely related to SSEA-1, we cloned genomic DNA encoding active variable regions both of heavy and light chains of the antibody. Sequence analysis showed that V(H) and V(kappa) genes of H18A were in the V(H)7183 family and V(kappa)C1 family, respectively. A transfected cell line named HC-H18A-7 expressing a recombinant chimeric H18A composed of mouse-derived antigen-binding variable regions and human-derived constant regions was established. The chimeric H18A was purified to homogeneity and shown to bind purified Lewis Y antigen with the same dose-response curve as the original H18A. The chimeric H18A looks more promising for clinical application than the original mouse-derived H18A because its antigenicity is expected to be reduced.
引用
收藏
页码:114 / 117
页数:4
相关论文
共 16 条
[1]  
ABE K, 1983, J BIOL CHEM, V258, P1793
[2]   COORDINATE EXPRESSION OF X-HAPTENS AND Y-HAPTENS DURING MURINE EMBRYOGENESIS [J].
FENDERSON, BA ;
HOLMES, EH ;
FUKUSHI, Y ;
HAKOMORI, S .
DEVELOPMENTAL BIOLOGY, 1986, 114 (01) :12-21
[3]   STAGE-SPECIFIC EMBRYONIC ANTIGEN INVOLVES ALPHA-1-]3 FUCOSYLATED TYPE-2 BLOOD-GROUP CHAINS [J].
GOOI, HC ;
FEIZI, T ;
KAPADIA, A ;
KNOWLES, BB ;
SOLTER, D ;
EVANS, MJ .
NATURE, 1981, 292 (5819) :156-158
[4]  
HAMADA H, 1990, CANCER RES, V50, P3167
[5]  
HIRASHIMA K, 1990, J IMMUNOL, V145, P224
[6]   HUMAN MOUSE CHIMERIC ANTIBODIES SHOW LOW REACTIVITY WITH HUMAN ANTIMURINE ANTIBODIES (HAMA) [J].
HOSONO, M ;
ENDO, K ;
SAKAHARA, H ;
WATANABE, Y ;
SAGA, T ;
NAKAI, T ;
KAWAI, C ;
MATSUMORI, A ;
YAMADA, T ;
WATANABE, T ;
KONISHI, J .
BRITISH JOURNAL OF CANCER, 1992, 65 (02) :197-200
[7]  
Kabat E.A., 1991, SEQUENCES PROTEINS I, V5th
[8]   CONVENIENT PLASMID VECTORS FOR CONSTRUCTION OF CHIMERIC MOUSE HUMAN-ANTIBODIES [J].
KAMEYAMA, KZ ;
IMAI, K ;
ITOH, T ;
TANIGUCHI, M ;
MIURA, K ;
KUROSAWA, Y .
FEBS LETTERS, 1989, 244 (02) :301-306
[9]  
KANNAGI R, 1982, J BIOL CHEM, V257, P4865
[10]   BIOLOGICAL AND CLINICAL IMPLICATIONS OF LYMPHOCYTE HYBRIDOMAS - TUMOR-THERAPY WITH MONOCLONAL-ANTIBODIES [J].
LEVY, R ;
MILLER, RA .
ANNUAL REVIEW OF MEDICINE, 1983, 34 :107-116